27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

BHC Insider Trading (Bausch Health Companies)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): C$330,162.36

Insider Selling (Last 12 Months): C$645,369.76

Bausch Health Companies Insider Trading History Chart

Bausch Health Companies Share Price & Price History

C^$13.85

▼ -0.15 (-1.07%)

As of 05/16/2022 01:00 AM ET

Days: 30 | 90 | 365

Nevada Desert more Valuable than Wall Street or Silicon Valley?

From Investing Trends | Ad

It could be true, according to Nevada Governor Steve Sisolak. The state's desert flats contain more lithium than any other geography in the world. And with electric vehicles driving a global boom in demand for lithium-ion batteries, Nevada should be on every investor's radar.

Find Out How to Take Advantage of Nevada's Lithium

Bausch Health Companies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/14/2022	Robert Allen Spurr	Senior Officer	Sell	1,595	C$27.96	C$44,595.24	24,617
3/15/2022	Robert Allen Spurr	Senior Officer	Sell	4,846	C$28.42	C$137,703.94	26,212
8/4/2021	Richard Urbain De Schutter	Director	Buy	10,000	C$33.02	C$330,162.36	280,857
5/26/2021	Amy Wechsler	Director	Sell	11,037	C$41.96	C$463,070.58
9/8/2020	William Douglas Humphries	Senior Officer	Sell	5,667	C$21.34	C$120,958.71	190,912
9/13/2019	Joseph Papa	Director	Buy	30,000	C$30.77	C$923,076.00	473,284
8/16/2019	William Douglas Humphries	Senior Officer	Buy	30,703	C$27.95	C$858,187.66	89,220
8/12/2019	Christina Ackermann	Senior Officer	Sell	3,418	C$29.63	C$101,277.73	7,385
7/11/2019	Christina Ackermann	Senior Officer	Sell	3,968	C$32.75	C$129,948.83	3,967

Bargain in Today's Market (SHOCKING)

From Oxford Club | Ad

This "World's Most Admired" company's stock would be a bargain at $50...Today it's just $2! Plus... a key May 12 announcement could send it ROCKETING skyward...

Click Here Now (Before It's Too Late!)

>>>

SEC Filings (Institutional Ownership Changes) for Bausch Health Companies (TSE:BHC)

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Today's Range

Now: C$13.85

C$13.61

C$14.44

50 Day Range

MA: C$26.13

C$12.23

C$30.48

52 Week Range

Now: C$13.85

C$10.12

C$39.11

Volume

1,460,810 shs

Average Volume

628,517 shs

Market Capitalization

C$5.01 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Bausch Health Companies?: Bausch Health Companies' top insider shareholders include:
Richard Urbain De Schutter (Director)
William Douglas Humphries (Senior Officer)
Robert Allen Spurr (Senior Officer)
Amy Wechsler (Director)
Learn More about top insider investors at Bausch Health Companies.

This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)